Industry Analysis & Industry Trends
The Biotechnology industry is fast becoming a prominent part of the UK life sciences scene alongside pharmaceutical and medical technology firms. The convergence of these three technologies is making it ever more difficult to identify the boundaries between them. The Biotechnology industry relies heavily on third-party financing, so the economic downturn posed funding challenges. Dented business confidence made private financiers uncertain about investing in risky research and development (R&D) projects. This has dampened growth, but not contained it. Britain's ageing, ailing population wants advanced treatment options to ward off natural bodily decline and the Biotechnology industry has managed to attract persistently high levels of private investment to research this area of interest... purchase to read more
Industry Report - Industry Investment Chapter
The level of investment required is determined by comparing the human and capital equipment factors of production, using wages and depreciation costs as proxies. Comparatively high depreciation costs are indicative of a high level of investment in depreciable assets such as buildings and equipment, and therefore high capital intensity. Conversely, comparatively high wages costs indicate high labour intensity.
The industry relies on the application of knowledge by highly skilled staff in the research and development of biotechnology products... purchase to read more